| 04-Apr-2005 | S | Decided to split the equity shares of face value of Rs 2/- into face value of Re. 1/- each subject to approval of members at General Meeting of the company.
EGM 05/03/2005
To consider split of shares into face value of Re. 1/- each and alteration of Capital Clause of aMemorandum of Association of the Company.
(As per BSE bulletin dated 07/02/2005)
SUB. :- Sub Division of equity shares of Sterling Biotech Ltd. (Scrip Code 512299).
Members of the Exchange are hereby informed that, Sterling Biotech Ltd. has fixed the Record Date for the purpose of sub division of its equity shares.
SUB- DIVIDED PAID-UP VALUE Re.1/-
SUB-DIVIDED PAID-UP VALUE W.E.F. 18/03/2005
Sub Division of existing equity shares from every ONE equity share of Rs.2/- each into TWO equity shares of Re.1/- each.
The auction in the equity shares of Sterling Biotech Ltd. in Dematerialised Securities - Rolling Settlement Segment on 18/03/2005, 21/03/2005 and 22/03/2005 will be conducted as per face value of Rs.2/- each. Members are, therefore, requested to take abundant precautions while mentioning the rates for offering the equity shares of the said company in auction on the said dates.
The scrip will be No Delivery from 18/03/2005 (DR-248/2004-2005) to 23/03/2005 (DR-251/2004-2005).
Note :-
i.Members are hereby informed that thetransactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Re.1/- paid up w.e.f. 18.03.2005.
ii. ISIN No. INE324C01020 of Rs.2/- paid up will be discontinued w.e.f.18.03.2005 and the new ISIN Number for Re.1/- paid up will be informed to the market by a separate notice.
(As per BSE Notice dated on 10/03/2005)
In continuation of the Exchange Notice 20050401-15 dated April 1, 2005 regarding listing of equity shares of Sterling Biotech Limited, members of the Exchange are hereby informed that the new ISIN Number of the company is INE324C01038. Further it may be noted that due to sub-division of shares from Rs.2/- to Re.1/-, the conversion price shall be Rs.77.73 per share of Re.1/- each and not as mentioned in the aforesaid notice.
(As per BSE Notice dated on 04/04/2005) | 26-Mar-2005 | |
| 27-Dec-2001 | S | Sub-division of existing equity share - from every one existing equity share of Rs.10/- each into five equity shares of Rs.2/- each.
Reduced Paid-up value - Rs.2/-
Reduced Paid-up value w.e.f. - 07/01/2002
(For Demat Securities) | 19-Jan-2002 | |
| 31-May-2011 | D | Sterling Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 31, 2011, inter alia, has recommended 50% [Rs. 0.50 per equity share of F.V. of Re. 1/- each] dividend on the equity shares for the financial year ended December 31, 2010 subject to approval of the members at the ensuing Annual General Meeting. | 21-Jun-2011 | |
| 31-Mar-2010 | D | Sterling Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 31, 2010, has recommended 50% (Rs. 0.50 per equity share of F.V. of Re. 1/- each) dividend on the equity shares for the financial year ended December 31, 2009 subject to approval of the members at the ensuing Annual General Meeting. | 21-Jun-2010 | |
| 31-Mar-2009 | D | Sterling Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 31, 2009, inter alia, has recommended 50% (Rs 0.50 per equity share of F.V. of Re 1/- each) dividend on the equity shares for the financial year ended December 31, 2008, subject to approval of the members.
Sterling Biotech Limited has informed the Exchange that the Annual General Meeting for the financial year ended on December 31, 2008 will be held on June 30, 2009. Further, the Register of Members and Share Transfer Books of the Company shall remain closed from June 23, 2009 to June 30, 2009 (both days inclusive) for the purpose of payment of Dividend for the financial year ended on December 31, 2008 @50% per equity share of Re.1/- each recommended by the Board of Directors of the Company at their meeting held on March 31, 2009 subject to confirmation of members at the Annual General Meeting of the Company.
(As per NSE Bulletin Dated on 03.06.2009) | 19-Jun-2009 | |
| 31-Mar-2008 | D | Sterling Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 31, 2008, inter alia, has recommended 50% (Rs 0.50 per equity shares of FV of Rs 1/-) dividend on the equity shares for the financial year ended December 31, 2007 subject to approval of the members. | 22-May-2008 | |
| 29-Mar-2007 | D | Sterling Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 29, 2007, inter alia, has recommended 50% (Rs 0.50 per equity shares of FV of Rs 1/-) dividend on the equity shares for the financial year ended December 31, 2006 subject to approval of the members at the ensuing Annual General Meeting of the Company.
Sc-Code 612299 | 03-May-2007 | |
| 25-May-2006 | D | 50% Dividend
(As per BSE Bulletin dated on 26/05/2006) | 15-Jun-2006 | |
| 24-Feb-2023 | BC | Trading Members of the Exchange are hereby informed that pursuant to Liquation order by the Hon'ble National Company Law Tribunal, Mumbai Bench dated November 11, 2022, Sterling Biotech Limited ('the | 03-Mar-2023 | |
| 24-Feb-2023 | BC | Sub: Voluntary Delisting - Sterling Biotech Limited
It is hereby notified that the admission to dealings in the following security shall be withdrawn
(delisted) w.e.f. March 03, 2023.
Symbol
| 03-Mar-2023 | |
| 02-Feb-2019 | BC | STERLING BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2019 ,inter alia, to consider and approve Dear Sir / Madam, We would like to in | 11-Feb-2019 | |
| 24-Jan-2019 | BC | STERLING BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2019 ,inter alia, to consider and approve Dear Sir / Madam, We would like to in | 01-Feb-2019 | |
| 23-Oct-2018 | BC | This is in continuation to Exchange Notice No. 20180327-46 dated March 27, 2018 wherein the Trading Members were advised that w.r.t to the following companies, 15 days after suspension had been effec | 06-Nov-2018 | |
Announcement Date31-May-2011
Ex Dividend Date21-Jun-2011
Dividend(%)50
Announcement Date31-Mar-2010
Ex Dividend Date21-Jun-2010
Dividend(%)50
Announcement Date31-Mar-2009
Ex Dividend Date19-Jun-2009
Dividend(%)50
Announcement Date31-Mar-2008
Ex Dividend Date22-May-2008
Dividend(%)50
Announcement Date29-Mar-2007
Ex Dividend Date03-May-2007
Dividend(%)50
Announcement Date25-May-2006
Ex Dividend Date15-Jun-2006
Dividend(%)50
No Bonus has been declared by STERLINBIO
Record Date26-Mar-2005
Split Date18-Mar-2005
Face Value (Before/After)2/1
Record Date19-Jan-2002
Split Date07-Jan-2002
Face Value (Before/After)10/2
RightsNo Rights has been declared by STERLINBIO
Book Closure
| 03-Mar-2023 | - | Trading Members of the Exchange are hereby informed that pursuant to Liquation order by the Hon'ble National Company Law Tribunal, Mumbai Bench dated November 11, 2022, Sterling Biotech Limited ('the |
| 03-Mar-2023 | - | Sub: Voluntary Delisting - Sterling Biotech Limited
It is hereby notified that the admission to dealings in the following security shall be withdrawn
(delisted) w.e.f. March 03, 2023.
Symbol
|
| 11-Feb-2019 | - | STERLING BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2019 ,inter alia, to consider and approve Dear Sir / Madam, We would like to in |
| 01-Feb-2019 | - | STERLING BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2019 ,inter alia, to consider and approve Dear Sir / Madam, We would like to in |
| 06-Nov-2018 | - | This is in continuation to Exchange Notice No. 20180327-46 dated March 27, 2018 wherein the Trading Members were advised that w.r.t to the following companies, 15 days after suspension had been effec |